Loading insider details...
Beta
Latest Form 4 (Jul 6, 2026): Grant/Award of 13,786 KROS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 6, 2026 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 13,786 | n/a |
| Jun 20, 2025 | Galecto, Inc. (GLTO) | Grant/Award | 720 | n/a |
| Jun 21, 2024 | Galecto, Inc. (GLTO) | Grant/Award | 18,000 | n/a |
| Jun 15, 2023 | Galecto, Inc. (GLTO) | Grant/Award | 18,000 | n/a |
| Jun 15, 2022 | Galecto, Inc. (GLTO) | Grant/Award | 18,000 | n/a |
| May 28, 2021 | Galecto, Inc. (GLTO) | Grant/Award | 18,000 | n/a |
| Jan 8, 2021 | Galecto, Inc. (GLTO) | Grant/Award | 18,000 | n/a |